ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global mRNA Vaccine Raw Materials Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-36L18051
Home | Market Reports | Science
Global mRNA Vaccine Raw Materials Market Research Report 2024
BUY CHAPTERS

Global mRNA Vaccine Raw Materials Market Research Report 2024

Code: QYRE-Auto-36L18051
Report
August 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GMP
Thermo Fisher Scientific Inc
Danaher Corporation
Kaneka Eurogentec S.A.
Biospring
GenScript
Aji Bio-Pharma
Merck KGaA
Aldevron
Wuxi Biologics
Asymchem
Novoprotein
Vazyme
Yeasen
KACTUS
Hongene
Cosychem

mRNA Vaccine Raw Materials Market

The development and production of mRNA vaccines is relatively simple, scalable, and extremely rapid. mRNA is produced in vitro through an enzymatic process without the need to remove cells or host cell proteins. This simplified production process allows GMP facilities to be converted to produce new protein targets in a very short period of time, with only minimal changes to the process and formulation.
The global mRNA Vaccine Raw Materials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for mRNA Vaccine Raw Materials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for mRNA Vaccine Raw Materials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for mRNA Vaccine Raw Materials in (non-replicating) mRNA vaccine is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of mRNA Vaccine Raw Materials include Thermo Fisher Scientific Inc., Danaher Corporation, Kaneka Eurogentec S.A., BioSpring, GenScript, Aji Bio-Pharma, Merck KGaA, Aldevron, Hongene, WuXi Biologics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccine Raw Materials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccine Raw Materials.
The mRNA Vaccine Raw Materials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Vaccine Raw Materials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccine Raw Materials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of mRNA Vaccine Raw Materials Market Report

Report Metric Details
Report Name mRNA Vaccine Raw Materials Market
Segment by Type
Segment by Application
  • (non-replicating) mRNA vaccine
  • (self-amplifying) mRNA vaccine
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific Inc., Danaher Corporation, Kaneka Eurogentec S.A., BioSpring, GenScript, Aji Bio-Pharma, Merck KGaA, Aldevron, Hongene, WuXi Biologics, Asymchem, Cosychem, Novoprotein, Vazyme, Yeasen, KACTUS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of mRNA Vaccine Raw Materials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the mRNA Vaccine Raw Materials Market report?

Ans: The main players in the mRNA Vaccine Raw Materials Market are Thermo Fisher Scientific Inc., Danaher Corporation, Kaneka Eurogentec S.A., BioSpring, GenScript, Aji Bio-Pharma, Merck KGaA, Aldevron, Hongene, WuXi Biologics, Asymchem, Cosychem, Novoprotein, Vazyme, Yeasen, KACTUS

What are the Application segmentation covered in the mRNA Vaccine Raw Materials Market report?

Ans: The Applications covered in the mRNA Vaccine Raw Materials Market report are (non-replicating) mRNA vaccine, (self-amplifying) mRNA vaccine

What are the Type segmentation covered in the mRNA Vaccine Raw Materials Market report?

Ans: The Types covered in the mRNA Vaccine Raw Materials Market report are Plasmid DNA (pDNA), Enzyme, Other

Recommended Reports

Vaccine Technologies

Vaccine Storage & Logistics

Vaccine Adjuvants & Raw Materials

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Vaccine Raw Materials Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Plasmid DNA (pDNA)
1.2.3 Enzyme
1.2.4 Other
1.3 Market by Application
1.3.1 Global mRNA Vaccine Raw Materials Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 (non-replicating) mRNA vaccine
1.3.3 (self-amplifying) mRNA vaccine
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Vaccine Raw Materials Market Perspective (2019-2030)
2.2 Global mRNA Vaccine Raw Materials Growth Trends by Region
2.2.1 Global mRNA Vaccine Raw Materials Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 mRNA Vaccine Raw Materials Historic Market Size by Region (2019-2024)
2.2.3 mRNA Vaccine Raw Materials Forecasted Market Size by Region (2025-2030)
2.3 mRNA Vaccine Raw Materials Market Dynamics
2.3.1 mRNA Vaccine Raw Materials Industry Trends
2.3.2 mRNA Vaccine Raw Materials Market Drivers
2.3.3 mRNA Vaccine Raw Materials Market Challenges
2.3.4 mRNA Vaccine Raw Materials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Vaccine Raw Materials Players by Revenue
3.1.1 Global Top mRNA Vaccine Raw Materials Players by Revenue (2019-2024)
3.1.2 Global mRNA Vaccine Raw Materials Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Vaccine Raw Materials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by mRNA Vaccine Raw Materials Revenue
3.4 Global mRNA Vaccine Raw Materials Market Concentration Ratio
3.4.1 Global mRNA Vaccine Raw Materials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccine Raw Materials Revenue in 2023
3.5 Global Key Players of mRNA Vaccine Raw Materials Head office and Area Served
3.6 Global Key Players of mRNA Vaccine Raw Materials, Product and Application
3.7 Global Key Players of mRNA Vaccine Raw Materials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Vaccine Raw Materials Breakdown Data by Type
4.1 Global mRNA Vaccine Raw Materials Historic Market Size by Type (2019-2024)
4.2 Global mRNA Vaccine Raw Materials Forecasted Market Size by Type (2025-2030)
5 mRNA Vaccine Raw Materials Breakdown Data by Application
5.1 Global mRNA Vaccine Raw Materials Historic Market Size by Application (2019-2024)
5.2 Global mRNA Vaccine Raw Materials Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America mRNA Vaccine Raw Materials Market Size (2019-2030)
6.2 North America mRNA Vaccine Raw Materials Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America mRNA Vaccine Raw Materials Market Size by Country (2019-2024)
6.4 North America mRNA Vaccine Raw Materials Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Vaccine Raw Materials Market Size (2019-2030)
7.2 Europe mRNA Vaccine Raw Materials Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe mRNA Vaccine Raw Materials Market Size by Country (2019-2024)
7.4 Europe mRNA Vaccine Raw Materials Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Vaccine Raw Materials Market Size (2019-2030)
8.2 Asia-Pacific mRNA Vaccine Raw Materials Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific mRNA Vaccine Raw Materials Market Size by Region (2019-2024)
8.4 Asia-Pacific mRNA Vaccine Raw Materials Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Vaccine Raw Materials Market Size (2019-2030)
9.2 Latin America mRNA Vaccine Raw Materials Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America mRNA Vaccine Raw Materials Market Size by Country (2019-2024)
9.4 Latin America mRNA Vaccine Raw Materials Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Vaccine Raw Materials Market Size (2019-2030)
10.2 Middle East & Africa mRNA Vaccine Raw Materials Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa mRNA Vaccine Raw Materials Market Size by Country (2019-2024)
10.4 Middle East & Africa mRNA Vaccine Raw Materials Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Details
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Details
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation mRNA Vaccine Raw Materials Introduction
11.2.4 Danaher Corporation Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.2.5 Danaher Corporation Recent Development
11.3 Kaneka Eurogentec S.A.
11.3.1 Kaneka Eurogentec S.A. Company Details
11.3.2 Kaneka Eurogentec S.A. Business Overview
11.3.3 Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Introduction
11.3.4 Kaneka Eurogentec S.A. Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.3.5 Kaneka Eurogentec S.A. Recent Development
11.4 BioSpring
11.4.1 BioSpring Company Details
11.4.2 BioSpring Business Overview
11.4.3 BioSpring mRNA Vaccine Raw Materials Introduction
11.4.4 BioSpring Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.4.5 BioSpring Recent Development
11.5 GenScript
11.5.1 GenScript Company Details
11.5.2 GenScript Business Overview
11.5.3 GenScript mRNA Vaccine Raw Materials Introduction
11.5.4 GenScript Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.5.5 GenScript Recent Development
11.6 Aji Bio-Pharma
11.6.1 Aji Bio-Pharma Company Details
11.6.2 Aji Bio-Pharma Business Overview
11.6.3 Aji Bio-Pharma mRNA Vaccine Raw Materials Introduction
11.6.4 Aji Bio-Pharma Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.6.5 Aji Bio-Pharma Recent Development
11.7 Merck KGaA
11.7.1 Merck KGaA Company Details
11.7.2 Merck KGaA Business Overview
11.7.3 Merck KGaA mRNA Vaccine Raw Materials Introduction
11.7.4 Merck KGaA Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.7.5 Merck KGaA Recent Development
11.8 Aldevron
11.8.1 Aldevron Company Details
11.8.2 Aldevron Business Overview
11.8.3 Aldevron mRNA Vaccine Raw Materials Introduction
11.8.4 Aldevron Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.8.5 Aldevron Recent Development
11.9 Hongene
11.9.1 Hongene Company Details
11.9.2 Hongene Business Overview
11.9.3 Hongene mRNA Vaccine Raw Materials Introduction
11.9.4 Hongene Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.9.5 Hongene Recent Development
11.10 WuXi Biologics
11.10.1 WuXi Biologics Company Details
11.10.2 WuXi Biologics Business Overview
11.10.3 WuXi Biologics mRNA Vaccine Raw Materials Introduction
11.10.4 WuXi Biologics Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.10.5 WuXi Biologics Recent Development
11.11 Asymchem
11.11.1 Asymchem Company Details
11.11.2 Asymchem Business Overview
11.11.3 Asymchem mRNA Vaccine Raw Materials Introduction
11.11.4 Asymchem Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.11.5 Asymchem Recent Development
11.12 Cosychem
11.12.1 Cosychem Company Details
11.12.2 Cosychem Business Overview
11.12.3 Cosychem mRNA Vaccine Raw Materials Introduction
11.12.4 Cosychem Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.12.5 Cosychem Recent Development
11.13 Novoprotein
11.13.1 Novoprotein Company Details
11.13.2 Novoprotein Business Overview
11.13.3 Novoprotein mRNA Vaccine Raw Materials Introduction
11.13.4 Novoprotein Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.13.5 Novoprotein Recent Development
11.14 Vazyme
11.14.1 Vazyme Company Details
11.14.2 Vazyme Business Overview
11.14.3 Vazyme mRNA Vaccine Raw Materials Introduction
11.14.4 Vazyme Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.14.5 Vazyme Recent Development
11.15 Yeasen
11.15.1 Yeasen Company Details
11.15.2 Yeasen Business Overview
11.15.3 Yeasen mRNA Vaccine Raw Materials Introduction
11.15.4 Yeasen Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.15.5 Yeasen Recent Development
11.16 KACTUS
11.16.1 KACTUS Company Details
11.16.2 KACTUS Business Overview
11.16.3 KACTUS mRNA Vaccine Raw Materials Introduction
11.16.4 KACTUS Revenue in mRNA Vaccine Raw Materials Business (2019-2024)
11.16.5 KACTUS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
GMP
Thermo Fisher Scientific Inc
Danaher Corporation
Kaneka Eurogentec S.A.
Biospring
GenScript
Aji Bio-Pharma
Merck KGaA
Aldevron
Wuxi Biologics
Asymchem
Novoprotein
Vazyme
Yeasen
KACTUS
Hongene
Cosychem
List of Tables
 Table 1. Global mRNA Vaccine Raw Materials Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Plasmid DNA (pDNA)
 Table 3. Key Players of Enzyme
 Table 4. Key Players of Other
 Table 5. Global mRNA Vaccine Raw Materials Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global mRNA Vaccine Raw Materials Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global mRNA Vaccine Raw Materials Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global mRNA Vaccine Raw Materials Market Share by Region (2019-2024)
 Table 9. Global mRNA Vaccine Raw Materials Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global mRNA Vaccine Raw Materials Market Share by Region (2025-2030)
 Table 11. mRNA Vaccine Raw Materials Market Trends
 Table 12. mRNA Vaccine Raw Materials Market Drivers
 Table 13. mRNA Vaccine Raw Materials Market Challenges
 Table 14. mRNA Vaccine Raw Materials Market Restraints
 Table 15. Global mRNA Vaccine Raw Materials Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global mRNA Vaccine Raw Materials Market Share by Players (2019-2024)
 Table 17. Global Top mRNA Vaccine Raw Materials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine Raw Materials as of 2023)
 Table 18. Ranking of Global Top mRNA Vaccine Raw Materials Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by mRNA Vaccine Raw Materials Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of mRNA Vaccine Raw Materials, Headquarters and Area Served
 Table 21. Global Key Players of mRNA Vaccine Raw Materials, Product and Application
 Table 22. Global Key Players of mRNA Vaccine Raw Materials, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global mRNA Vaccine Raw Materials Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global mRNA Vaccine Raw Materials Revenue Market Share by Type (2019-2024)
 Table 26. Global mRNA Vaccine Raw Materials Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global mRNA Vaccine Raw Materials Revenue Market Share by Type (2025-2030)
 Table 28. Global mRNA Vaccine Raw Materials Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global mRNA Vaccine Raw Materials Revenue Market Share by Application (2019-2024)
 Table 30. Global mRNA Vaccine Raw Materials Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global mRNA Vaccine Raw Materials Revenue Market Share by Application (2025-2030)
 Table 32. North America mRNA Vaccine Raw Materials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America mRNA Vaccine Raw Materials Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America mRNA Vaccine Raw Materials Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe mRNA Vaccine Raw Materials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe mRNA Vaccine Raw Materials Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe mRNA Vaccine Raw Materials Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific mRNA Vaccine Raw Materials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific mRNA Vaccine Raw Materials Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific mRNA Vaccine Raw Materials Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America mRNA Vaccine Raw Materials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America mRNA Vaccine Raw Materials Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America mRNA Vaccine Raw Materials Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa mRNA Vaccine Raw Materials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa mRNA Vaccine Raw Materials Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa mRNA Vaccine Raw Materials Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Thermo Fisher Scientific Inc. Company Details
 Table 48. Thermo Fisher Scientific Inc. Business Overview
 Table 49. Thermo Fisher Scientific Inc. mRNA Vaccine Raw Materials Product
 Table 50. Thermo Fisher Scientific Inc. Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 51. Thermo Fisher Scientific Inc. Recent Development
 Table 52. Danaher Corporation Company Details
 Table 53. Danaher Corporation Business Overview
 Table 54. Danaher Corporation mRNA Vaccine Raw Materials Product
 Table 55. Danaher Corporation Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 56. Danaher Corporation Recent Development
 Table 57. Kaneka Eurogentec S.A. Company Details
 Table 58. Kaneka Eurogentec S.A. Business Overview
 Table 59. Kaneka Eurogentec S.A. mRNA Vaccine Raw Materials Product
 Table 60. Kaneka Eurogentec S.A. Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 61. Kaneka Eurogentec S.A. Recent Development
 Table 62. BioSpring Company Details
 Table 63. BioSpring Business Overview
 Table 64. BioSpring mRNA Vaccine Raw Materials Product
 Table 65. BioSpring Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 66. BioSpring Recent Development
 Table 67. GenScript Company Details
 Table 68. GenScript Business Overview
 Table 69. GenScript mRNA Vaccine Raw Materials Product
 Table 70. GenScript Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 71. GenScript Recent Development
 Table 72. Aji Bio-Pharma Company Details
 Table 73. Aji Bio-Pharma Business Overview
 Table 74. Aji Bio-Pharma mRNA Vaccine Raw Materials Product
 Table 75. Aji Bio-Pharma Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 76. Aji Bio-Pharma Recent Development
 Table 77. Merck KGaA Company Details
 Table 78. Merck KGaA Business Overview
 Table 79. Merck KGaA mRNA Vaccine Raw Materials Product
 Table 80. Merck KGaA Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 81. Merck KGaA Recent Development
 Table 82. Aldevron Company Details
 Table 83. Aldevron Business Overview
 Table 84. Aldevron mRNA Vaccine Raw Materials Product
 Table 85. Aldevron Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 86. Aldevron Recent Development
 Table 87. Hongene Company Details
 Table 88. Hongene Business Overview
 Table 89. Hongene mRNA Vaccine Raw Materials Product
 Table 90. Hongene Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 91. Hongene Recent Development
 Table 92. WuXi Biologics Company Details
 Table 93. WuXi Biologics Business Overview
 Table 94. WuXi Biologics mRNA Vaccine Raw Materials Product
 Table 95. WuXi Biologics Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 96. WuXi Biologics Recent Development
 Table 97. Asymchem Company Details
 Table 98. Asymchem Business Overview
 Table 99. Asymchem mRNA Vaccine Raw Materials Product
 Table 100. Asymchem Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 101. Asymchem Recent Development
 Table 102. Cosychem Company Details
 Table 103. Cosychem Business Overview
 Table 104. Cosychem mRNA Vaccine Raw Materials Product
 Table 105. Cosychem Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 106. Cosychem Recent Development
 Table 107. Novoprotein Company Details
 Table 108. Novoprotein Business Overview
 Table 109. Novoprotein mRNA Vaccine Raw Materials Product
 Table 110. Novoprotein Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 111. Novoprotein Recent Development
 Table 112. Vazyme Company Details
 Table 113. Vazyme Business Overview
 Table 114. Vazyme mRNA Vaccine Raw Materials Product
 Table 115. Vazyme Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 116. Vazyme Recent Development
 Table 117. Yeasen Company Details
 Table 118. Yeasen Business Overview
 Table 119. Yeasen mRNA Vaccine Raw Materials Product
 Table 120. Yeasen Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 121. Yeasen Recent Development
 Table 122. KACTUS Company Details
 Table 123. KACTUS Business Overview
 Table 124. KACTUS mRNA Vaccine Raw Materials Product
 Table 125. KACTUS Revenue in mRNA Vaccine Raw Materials Business (2019-2024) & (US$ Million)
 Table 126. KACTUS Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. mRNA Vaccine Raw Materials Picture
 Figure 2. Global mRNA Vaccine Raw Materials Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global mRNA Vaccine Raw Materials Market Share by Type: 2023 VS 2030
 Figure 4. Plasmid DNA (pDNA) Features
 Figure 5. Enzyme Features
 Figure 6. Other Features
 Figure 7. Global mRNA Vaccine Raw Materials Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global mRNA Vaccine Raw Materials Market Share by Application: 2023 VS 2030
 Figure 9. (non-replicating) mRNA vaccine Case Studies
 Figure 10. (self-amplifying) mRNA vaccine Case Studies
 Figure 11. mRNA Vaccine Raw Materials Report Years Considered
 Figure 12. Global mRNA Vaccine Raw Materials Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 13. Global mRNA Vaccine Raw Materials Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global mRNA Vaccine Raw Materials Market Share by Region: 2023 VS 2030
 Figure 15. Global mRNA Vaccine Raw Materials Market Share by Players in 2023
 Figure 16. Global Top mRNA Vaccine Raw Materials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine Raw Materials as of 2023)
 Figure 17. The Top 10 and 5 Players Market Share by mRNA Vaccine Raw Materials Revenue in 2023
 Figure 18. North America mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 19. North America mRNA Vaccine Raw Materials Market Share by Country (2019-2030)
 Figure 20. United States mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe mRNA Vaccine Raw Materials Market Share by Country (2019-2030)
 Figure 24. Germany mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. France mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. U.K. mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Italy mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Russia mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Nordic Countries mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific mRNA Vaccine Raw Materials Market Share by Region (2019-2030)
 Figure 32. China mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Japan mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. South Korea mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Southeast Asia mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. India mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Australia mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America mRNA Vaccine Raw Materials Market Share by Country (2019-2030)
 Figure 40. Mexico mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Brazil mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa mRNA Vaccine Raw Materials Market Share by Country (2019-2030)
 Figure 44. Turkey mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Saudi Arabia mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. UAE mRNA Vaccine Raw Materials Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Thermo Fisher Scientific Inc. Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 48. Danaher Corporation Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 49. Kaneka Eurogentec S.A. Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 50. BioSpring Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 51. GenScript Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 52. Aji Bio-Pharma Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 53. Merck KGaA Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 54. Aldevron Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 55. Hongene Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 56. WuXi Biologics Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 57. Asymchem Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 58. Cosychem Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 59. Novoprotein Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 60. Vazyme Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 61. Yeasen Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 62. KACTUS Revenue Growth Rate in mRNA Vaccine Raw Materials Business (2019-2024)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global mRNA Vaccine Core Enzyme Market Research Report 2025
Global GMP grade mRNA Production Market Research Report 2024
Global mRNA Vaccines Therapeutics Market Research Report 2024
Global mRNA Synthesis Manufacturing Market Research Report 2024
Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030
Global mRNA Therapy Market Research Report 2024
Global mRNA Raw Enzyme Market Research Report 2025
mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030
Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
mRNA Vaccine and Therapeutics Raw Material Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Development and Manufacturing Services Market Research Report 2025
Global Livestock mRNA Vaccines Market Research Report 2025
Global RNA Vaccines Market Insights Forecast to 2030
mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Treatment Market Research Report 2024
Global Veterinary mRNA Vaccines Market Research Report 2025
Global mRNA Vaccine Drugs Development Services Market Research Report 2024
mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Delivery System Market Research Report 2024

RELATED REPORTS

Global Fully Automatic Fluorescence Immunoprocessing System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18Z19864
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Correlative Light and Electron Microscopy（CLEM）Solutions Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7X16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Disposable Cell Culture Dishes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4O16883
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NAD+ Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11H16753
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions